Apr 14, 2023 | In press, NemoClinics, NeoPhen, Neurodiderot
In collaboration with Dr. Muriel Thoby-Brisson (Université de Bordeaux, Institut de Neurosciences Cognitives et Intégratives d’Aquitaine, CNRS), and thanks to Fondation Air Liquide, Association Française du syndrome d’Ondine and start-up company ATMOSR, team...
Apr 14, 2023 | In press, NeoPhen, Neurodiderot
Pierre Alexis Geoffroy and team NeoPhen published a study in J Clin Psychiatry [1], showing that dream alterations and their progression can be readily assessed and may help to better identify prodromal signs of suicidal behaviors. A study highlighted in Inserm...
